NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD
  • XY Feed
  • 24-HOUR Pass ↗
  • Push Notifications
Sign in Subscribe

Labcorp to Acquire Select BioReference Assets from OPKO Health in Deal Worth Up to $872 Million

Labcorp will buy select BioReference clinical, women’s health, and urology assets from OPKO Health for up to $872 million, adding 80+ patient service centers.

Labcorp to Acquire Select BioReference Assets from OPKO Health in Deal Worth Up to $872 Million
Credit: Labcorp
Already have an account? Sign in.
10/15/2026 · 1:40 PM
OPK
/ Read more

Feed↓

JPMorgan Initiates Praxis Precision With Overweight Rating and $700 Target, Implying 182% Upside
10/15/2026 · 5:06 PM

JPMorgan Initiates Praxis Precision With Overweight Rating and $700 Target, Implying 182% Upside

Analyst sees approvable assets and places stock on Positive Catalyst Watch.

/ Subscriber only
Thoma Bravo’s Proofpoint Agrees to Buy Varonis for $6.3 Billion
Featured/ 10/15/2026 · 4:43 PM

Thoma Bravo’s Proofpoint Agrees to Buy Varonis for $6.3 Billion

Shareholders get $49.75 per share, a 52% premium to the June 22 price.

/ Subscriber only
Semtech Plunges on Analyst Day as AI Growth Plans Fall Short of Market Hopes
10/15/2026 · 3:46 PM

Semtech Plunges on Analyst Day as AI Growth Plans Fall Short of Market Hopes

Semtech stock fell sharply following its Analyst Day as the company’s long-term $3.2 billion revenue goal failed to satisfy the market’s elevated expectations.

/ Subscriber only
Explore
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD
  • XY Feed
  • 24-HOUR Pass ↗
  • Push Notifications
More
  • Sign up
  • Sign in
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Terms/Privacy
  • UP↑
Get alerts

Be the first to know when deals break, stocks move, or biotech headlines hit.

Email address Subscribe
DON'T FALL BEHIND. ©2026
For informational purposes only. Not financial advice.
NOTRELOAD AI